27-hydroxycholesterol has been researched along with clofibrate in 1 studies
| Studies (27-hydroxycholesterol) | Trials (27-hydroxycholesterol) | Recent Studies (post-2010) (27-hydroxycholesterol) | Studies (clofibrate) | Trials (clofibrate) | Recent Studies (post-2010) (clofibrate) |
|---|---|---|---|---|---|
| 345 | 11 | 214 | 3,859 | 314 | 131 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, JZ; Matsui, J; Murakami, H; Suda, T; Tamasawa, N; Yamato, K | 1 |
1 other study(ies) available for 27-hydroxycholesterol and clofibrate
| Article | Year |
|---|---|
Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation.
Topics: Animals; Anticholesteremic Agents; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biological Transport; Blotting, Northern; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Clofibrate; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA-Binding Proteins; Drug Therapy, Combination; Hydroxycholesterols; Ketoconazole; Lipid Metabolism; Lipoproteins; Liver X Receptors; Male; Microsomes, Liver; Orphan Nuclear Receptors; Peroxisome Proliferators; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA; RNA, Messenger; Steroids; Transcription Factors; Up-Regulation | 2003 |